End-binding proteins sensitize microtubules to the action of microtubule-targeting agents

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 22, 2013, Pages 8900-8905

  Mohan, Renu ^a   Katrukha, Eugene A ^a   Doodhi, Harinath ^a   Smal, Ihor ^b   Meijering, Erik ^b   Kapitein, Lukas C ^a   Steinmetz, Michel O ^c   Akhmanova, Anna ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Biomolecular Research   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; ANTINEOPLASTIC AGENT; BINDING PROTEIN; COLCHICINE; COMBRETASTATIN A4; DOLASTATIN 15; END BINDING PROTEIN; MICROTUBULE PROTEIN; MICROTUBULE TARGETING AGENT; NAVELBINE; PACLITAXEL; PELORUSIDE A; PODOPHYLLOTOXIN; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE;

ARTICLE; CELL AGING; CELL GROWTH; CONTROLLED STUDY; DRUG MECHANISM; DRUG STABILITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROTUBULE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION;

EB1; EB3;

BICYCLO COMPOUNDS, HETEROCYCLIC; CELL AGING; COLCHICINE; DEPSIPEPTIDES; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LACTONES; MICROSCOPY, FLUORESCENCE; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MODELS, BIOLOGICAL; PACLITAXEL; PODOPHYLLOTOXIN; STATISTICS, NONPARAMETRIC; STILBENES; TUBULIN MODULATORS; VINBLASTINE;

EID: 84878434586     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1300395110     Document Type: Article

References (39)

1. Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4(4):253-265.
2. Amos LA (2011) What tubulin drugs tell us about microtubule structure and dynamics. Semin Cell Dev Biol 22(9):916-926.
3. Stanton RA, Gernert KM, Nettles JH, Aneja R (2011) Drugs that target dynamic microtubules: A new molecular perspective. Med Res Rev 31(3):443-481.
4. Zhou J, Giannakakou P (2005) Targeting microtubules for cancer chemotherapy. Curr Med Chem Anticancer Agents 5(1):65-71.
5. Ballatore C, et al. (2012) Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies. J Med Chem 55(21): 8979-8996.
6. Calligaris D, et al. (2010) Microtubule targeting agents: From biophysics to proteomics. Cell Mol Life Sci 67(7):1089-1104.
7. Gardner MK, Zanic M, Gell C, Bormuth V, Howard J (2011) The depolymerizing kinesins Kip3 (kinesin-8) and MCAK (kinesin-13) are catastrophe factors that destabilize microtubules by different mechanisms. Cell 147(5):1092-1103.
8. Odde DJ, Cassimeris L, Buettner HM (1995) Kinetics of microtubule catastrophe assessed by probabilistic analysis. Biophys J 69(3):796-802.
9. Gardner MK, Zanic M, Howard J (2013) Microtubule catastrophe and rescue. Curr Opin Cell Biol 25(1):14-22.
10. Akhmanova A, Steinmetz MO (2008) Tracking the ends: A dynamic protein network controls the fate of microtubule tips. Nat Rev Mol Cell Biol 9(4):309-322.
11. Howard J, Hyman AA (2003) Dynamics and mechanics of the microtubule plus end. Nature 422(6933):753-758.
12. Kumar P, Wittmann T (2012) +TIPs: SxIPping along microtubule ends. Trends Cell Biol 22(8):418-428.
13. Bieling P, et al. (2007) Reconstitution of a microtubule plus-end tracking system in vitro. Nature 450(7172):1100-1105.
14. Maurer SP, Fourniol FJ, Bohner G, Moores CA, Surrey T (2012) EBs recognize a nucleotide-dependent structural cap at growing microtubule ends. Cell 149(2):371-382.
15. Seetapun D, Castle BT, McIntyre AJ, Tran PT, Odde DJ (2012) Estimating the microtubule GTP cap size in vivo. Curr Biol 22(18):1681-1687.
16. Komarova Y, et al. (2009) Mammalian end binding proteins control persistent microtubule growth. J Cell Biol 184(5):691-706.
17. Montenegro Gouveia S, et al. (2010) In vitro reconstitution of the functional interplay between MCAK and EB3 at microtubule plus ends. Curr Biol 20(19):1717-1722.
18. Smal I, Grigoriev I, Akhmanova A, Niessen WJ, Meijering E (2009) Accurate estimation of microtubule dynamics using kymographs and variable-rate particle filters. Conf Proc IEEE Eng Med Biol Soc 2009:1012-1015.
19. Ngan VK, et al. (2000) Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules. Cancer Res 60(18):5045-5051.
20. Panda D, Jordan MA, Chu KC, Wilson L (1996) Differential effects of vinblastine on polymerization and dynamics at opposite microtubule ends. J Biol Chem 271(47): 29807-29812.
21. Toso RJ, Jordan MA, Farrell KW, Matsumoto B, Wilson L (1993) Kinetic stabilization of microtubule dynamic instability in vitro by vinblastine. Biochemistry 32(5):1285-1293.
22. Panda D, Daijo JE, Jordan MA, Wilson L (1995) Kinetic stabilization of microtubule dynamics at steady state in vitro by substoichiometric concentrations of tubulincolchicine complex. Biochemistry 34(31):9921-9929.
23. Huzil JT, et al. (2008) A unique mode of microtubule stabilization induced by peloruside A. J Mol Biol 378(5):1016-1030.
24. Pagano A, et al. (2012) Epothilone B inhibits migration of glioblastoma cells by inducing microtubule catastrophes and affecting EB1 accumulation at microtubule plus ends. Biochem Pharmacol 84(4):432-443.
25. Chan A, Andreae PM, Northcote PT, Miller JH (2011) Peloruside A inhibits microtubule dynamics in a breast cancer cell line MCF7. Invest New Drugs 29(4):615-626.
26. Yenjerla M, Cox C, Wilson L, Jordan MA (2009) Carbendazim inhibits cancer cell proliferation by suppressing microtubule dynamics. J Pharmacol Exp Ther 328(2): 390-398.
27. Pourroy B, et al. (2006) Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells. Cancer Res 66(6):3256-3263.
28. Gardner MK, et al. (2011) Rapid microtubule self-assembly kinetics. Cell 146(4): 582-592.
29. Dorléans A, et al. (2009) Variations in the colchicine-binding domain provide insight into the structural switch of tubulin. Proc Natl Acad Sci USA 106(33):13775-13779.
30. Gigant B, et al. (2005) Structural basis for the regulation of tubulin by vinblastine. Nature 435(7041):519-522.
31. Maurer SP, Bieling P, Cope J, Hoenger A, Surrey T (2011) GTPgammaS microtubules mimic the growing microtubule end structure recognised by end-binding proteins (EBs). Proc Natl Acad Sci USA 108(10):3988-3993.
32. Elie-Caille C, et al. (2007) Straight GDP-tubulin protofilaments form in the presence of taxol. Curr Biol 17(20):1765-1770.
33. Prota AE, et al. (2013) Molecular mechanism of action of microtubule-stabilizing anticancer agents. Science 339(6119):587-590.
34. Derry WB, Wilson L, Jordan MA (1998) Low potency of taxol at microtubule minus ends: Implications for its antimitotic and therapeutic mechanism. Cancer Res 58(6): 1177-1184.
35. Jordan MA, Toso RJ, Thrower D, Wilson L (1993) Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90(20):9552-9556.
36. Derry WB, Wilson L, Jordan MA (1995) Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry 34(7):2203-2211.
37. Bakhoum SF, Compton DA (2012) Kinetochores and disease: Keeping microtubule dynamics in check!. Curr Opin Cell Biol 24(1):64-70.
38. Brieher WM, Yap AS (2013) Cadherin junctions and their cytoskeleton(s). Curr Opin Cell Biol 25(1):39-46.
39. Stehbens S, Wittmann T (2012) Targeting and transport: How microtubules control focal adhesion dynamics. J Cell Biol 198(4):481-489.